戻る
Helix BioMedix Inc (HXBM)価格
HXBM 株価推移チャート
HXBM 収入
Helix BioMedix Inc
$1.75
-12.5%
$-0.25
終値： Jan 23, 16:00:00 GMT-5
$1.75
0%
$0
アフターマーケット：Jan 23, 18:10:57 GMT-5
主要データ
前終値
$2
始値
$1.75
当日レンジ
$1.75 - $1.75
52週レンジ
$1.75 - $7.19
取引高
200
平均取引高
31
1株当たり利益(TTM)
-15.60
配当利回り
--
時価総額
$402.5K
HXBMとは何ですか？
Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company is headquartered in Bothell, Washington and currently employs 8 full-time employees. The company went IPO on 2000-07-25. The firm is in the preclinical stage of development and intends to file for orphan drug designation prior to entering the clinical development pathway. Its legacy business consists of an proprietary library of patented bioactive peptides. Its lead drug development candidate, HB4208, is a polypeptide DNA deoxyribonucleic (DNA) damage response (DDR) enzyme for topical treatment of the rare genetic disorder (orphan disease) XP. Its intellectual property portfolio offers multiple pathways for commercialization in this area ranging from Rx dermatology to aesthetic dermatology and personal care. The company is developing new treatment options for dermatologic conditions which offer the therapeutic effectiveness and safety benefits of its advanced bioactive small molecule technology. The company is also engaged in the treatment of skin conditions.
